3/13
02:07 am
adap
Adaptimmune Therapeutics plc (NASDAQ: ADAP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Medium
Report
Adaptimmune Therapeutics plc (NASDAQ: ADAP) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
12/19
07:50 am
adap
Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK [Yahoo! Finance]
Neutral
Report
Adaptimmune Announces Changes to its Executive Leadership Team Based in The UK [Yahoo! Finance]